DrugPatentWatch Database Preview
Novast Labs Company Profile
Email this page to a colleague
» See Plans and PricingWhat is the competitive landscape for NOVAST LABS, and what generic and branded alternatives to NOVAST LABS drugs are available?
NOVAST LABS has fifty-nine approved drugs.
There are three tentative approvals on NOVAST LABS drugs.
Summary for Novast Labs
| US Patents: | 0 |
| Tradenames: | 57 |
| Ingredients: | 43 |
| NDAs: | 59 |
Drugs and US Patents for Novast Labs
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novast Labs | LIDOCAINE | lidocaine | OINTMENT;TOPICAL | 208604-001 | Sep 20, 2017 | AT | RX | No | No | Start Trial | Start Trial | ||||
| Novast Labs | DESIPRAMINE HYDROCHLORIDE | desipramine hydrochloride | TABLET;ORAL | 204963-001 | Dec 26, 2017 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Novast Labs | LARIN 24 FE | ethinyl estradiol; norethindrone acetate | TABLET;ORAL | 202994-001 | Feb 18, 2015 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Novast Labs | METFORMIN HYDROCHLORIDE | metformin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 209674-001 | Nov 2, 2018 | AB2 | RX | No | No | Start Trial | Start Trial | ||||
| Novast Labs | LERIBANE | ethinyl estradiol; norethindrone acetate | TABLET;ORAL | 203435-001 | Jun 3, 2016 | AB | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
